| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/19/2006 | US20060234259 analyzing levels of actin-binding protein, alpha-methylacyl-CoA racemase, cylcin-dependent kinase 7, integrins, notch protein ligands, kindney anion exchanger adaptor proteins, monoclonal antibodies, mucins, metastasis-associated protein, prostate specific antigen, and tumor antigens; drug screening |
| 10/19/2006 | US20060234258 Stanniocalcin (STC1) mRNA assay method |
| 10/19/2006 | US20060234257 NOVX nucleic acids and their encoded polypeptides; diagnostic and therapeutic applications in the detection of a variety of diseases with differential expression in normal vs. diseased tissues, e.g., detection of a variety of cancers. |
| 10/19/2006 | US20060234256 Double stranded RNA receptor (dsRNA-R) and methods relating thereto |
| 10/19/2006 | US20060234255 Novel proteins and nucleic acids encoding same |
| 10/19/2006 | US20060234254 Colon cancer biomarker discovery |
| 10/19/2006 | US20060234253 Method for detecting a target substance by using a nucleic acid probe |
| 10/19/2006 | US20060234252 Methods and kits for methylation detection |
| 10/19/2006 | US20060234251 Methods of enhancing isolation of RNA from biological samples |
| 10/19/2006 | US20060234250 Methods of screening and compositions for life span modulators |
| 10/19/2006 | US20060234249 Novel assays for assessing cancerous cell growth |
| 10/19/2006 | US20060234248 Composite organic inorganic nanoclusters |
| 10/19/2006 | US20060234247 Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing |
| 10/19/2006 | US20060234246 diagnosing cancer; drug screening; inhibiting growth of a tumor cell by modulating expression of a gene product |
| 10/19/2006 | US20060234245 Pathogenic gene for coronary artery disease |
| 10/19/2006 | US20060234244 System for analyzing bio chips using gene ontology and a method thereof |
| 10/19/2006 | US20060234243 Sample preparing unit |
| 10/19/2006 | US20060234242 Methods for identifying therapeutic targets involved in glucose and lipid metabolism |
| 10/19/2006 | US20060234241 Microchip, nucleic acid extracting kit, and nucleic acid extracting method |
| 10/19/2006 | US20060234240 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 1f receptor (5-ht1f) |
| 10/19/2006 | US20060234239 An oligonucleotide targeted to (hybridizing with) a nucleic acid molecule encoding human insulin like growth factor I receptor; treatment of proliferative and inflammatory skin disorders and cancer |
| 10/19/2006 | US20060234238 Polymerase-based protocols for generating chimeric oligonucleotides |
| 10/19/2006 | US20060234237 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
| 10/19/2006 | US20060234236 Simultaneous investigation of a plurality of target sequences or a plurality of mutations of a target sequence in a simple manner; detect binding or hybridization events in a microspot from the start of the PCR, without interruption of the ongoing reaction cycles and with minimum equipment |
| 10/19/2006 | US20060234235 Methods and compositions for the diagnosis of neuroendocrine lung cancer |
| 10/19/2006 | US20060234234 Nucleic acid amplification primers for pcr-based clonality studies |
| 10/19/2006 | US20060234233 Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes |
| 10/19/2006 | US20060234232 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 10/19/2006 | US20060234230 Method of detecting gene polymorphism |
| 10/19/2006 | US20060234228 Method of identifying nucleic acid |
| 10/19/2006 | US20060234227 Helix-hairpin-helix motifs to manipulate properties of dna processing enzymes |
| 10/19/2006 | US20060234225 Height-related gene |
| 10/19/2006 | US20060234224 Method and nucleic acids for the analysis of colon cell proliferative disorders |
| 10/19/2006 | US20060234223 Association of snps in the comt locus and neighboring loci with schizophrenia, bipolar disorder, breast cancer and colorectal cancer |
| 10/19/2006 | US20060234222 Soluble recombinant protein production |
| 10/19/2006 | US20060234221 Biallelic markers of d-amino acid oxidase and uses thereof |
| 10/19/2006 | US20060234220 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
| 10/19/2006 | US20060234219 Rapid and with high sensitivity; determining causative microorganisms of sepsis and those of bacteriemia |
| 10/19/2006 | US20060234218 P450 proteins |
| 10/19/2006 | US20060234217 Nucleic acid encodes a heat labile alkaline phosphatase, or the complementary sequence |
| 10/19/2006 | US20060234216 Nucleotide sequences coding polypeptide for use in the treatment of transport protein and hearing defect |
| 10/19/2006 | US20060234215 Rapid exchange luminescence (REL) for high sensitivity detection |
| 10/19/2006 | US20060234214 Methods of detecting hepatitis C virus |
| 10/19/2006 | US20060234213 Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses |
| 10/19/2006 | US20060234212 Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
| 10/19/2006 | US20060234211 Arterivirus (RNA enveloped virus); polypeptides with sensitivity and specificity; decreasing the incidence of false positives in a diagnostic assay |
| 10/19/2006 | US20060234210 Filtration device and method for removing selected materials from biological fluids |
| 10/19/2006 | US20060234209 Microchip-based system for hiv diagnostics |
| 10/19/2006 | US20060234208 Novel mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 10/19/2006 | US20060234207 Device for evaluating in vitro cell migration under flow conditions, and methods of use thereof |
| 10/19/2006 | US20060234206 environment-sensitive fluorophores which have spectroscopic behavior that is dependent on the physicochemical properties of the surrounding environment; 6-(Dimethylamino)-2,3-naphthalenedicarboylic anhydride |
| 10/19/2006 | US20060234205 In vitro test system for predicting patient tolerability of therapeutic agents |
| 10/19/2006 | US20060233899 Treatment of Human Multiple Myeloma by Curcumin |
| 10/19/2006 | US20060233836 Complex comprising peptide substrate such as synaptosomal associated protein, syntaxin, isoforms, vesicle-associated membrane protein, and motif of soluble NSF (N-ethylmaleimide-sensitive fusion protein) attachment protein receptor, reporter domain comprising red fluorescent protein |
| 10/19/2006 | US20060233832 Composition for the prophylaxis and treatment of HBV infections and HBV-mediated diseases |
| 10/19/2006 | US20060233823 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 10/19/2006 | US20060233822 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof |
| 10/19/2006 | US20060233821 Compositions and methods for the inhibition of membrane fusion by paramyxoviruses |
| 10/19/2006 | US20060233818 Organic compounds |
| 10/19/2006 | US20060233807 Novel therapies and methods of screening for therapeutic compounds |
| 10/19/2006 | US20060233803 treating an inflammatory disorder characterized by elevated expression of the polypeptide of SEQ ID NO: 32 in human, comprising administering an immunoadhesin comprising an extracellular domain sequence of the polypeptide; rheumatoid arthritis, pneumonia, chronic asthma, chronic hepatitis, osteoarthritis |
| 10/19/2006 | US20060233801 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 10/19/2006 | US20060233784 ADAMTS13 genes and proteins and variants, and uses thereof |
| 10/19/2006 | US20060233769 Established cell line of microglia |
| 10/19/2006 | US20060233744 Orthogonal tRNA synthetase that aminoacylates with reduced efficiency; lower km and recognizes selector codon in mRNA |
| 10/19/2006 | US20060231421 Method for Determination of Analyte Concentrations and Related Apparatus |
| 10/19/2006 | US20060231396 Thin analyzing device |
| 10/19/2006 | DE202005009490U1 Vorrichtung zur Anreicherung/Abtrennung von nicht-methylierte CpG-Motive enthaltender DNA Apparatus for enrichment / separation of non-methylated CpG motifs containing DNA |
| 10/19/2006 | DE10338308B4 Verfahren zum Nachweis von Cytosin-Methylierungen in DNA A method for the detection of cytosine methylations in DNA |
| 10/19/2006 | CA2616085A1 Rapid generation of long synthetic centromeric tandem repeats for mammalian artificial chromosome formation |
| 10/19/2006 | CA2605377A1 Ghrelin binding nucleic acids |
| 10/19/2006 | CA2604885A1 Cacna1e in cancer diagnosis, detection and treatment |
| 10/19/2006 | CA2604884A1 Ddr2 in cancer diagnosis, detection and treatment |
| 10/19/2006 | CA2604844A1 Cancer-related genes |
| 10/19/2006 | CA2604803A1 In vitro method for identifying compounds for cancer therapy |
| 10/19/2006 | CA2604714A1 Error detection in analyte measurements based on measurement of system resistance |
| 10/19/2006 | CA2604707A1 Method for determination of analyte concentrations and related apparatus |
| 10/19/2006 | CA2604625A1 A method of treating cancer using dichloroacetate |
| 10/19/2006 | CA2604554A1 A method for detecting c. albicans |
| 10/19/2006 | CA2604549A1 Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds |
| 10/19/2006 | CA2604493A1 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
| 10/19/2006 | CA2604442A1 Pharmaceutical compositions for and methods of inhibiting hcv replication |
| 10/19/2006 | CA2604386A1 Analyte determination method and analyte meter |
| 10/19/2006 | CA2604300A1 Anti-egfr antibody therapy based on an increased copy number of the egfr gene in tumor tissues |
| 10/19/2006 | CA2604187A1 Selection of highly efficient antigen presenting cells for regulating immunity and uses thereof |
| 10/19/2006 | CA2604135A1 Pop2 nfkb-inhibiting polypeptides, nucleic acids and methods of use |
| 10/19/2006 | CA2604095A1 Methods for determining sequence variants using ultra-deep sequencing |
| 10/19/2006 | CA2603949A1 Elite event a5547-127 and methods and kits for identifying such event in biological samples |
| 10/19/2006 | CA2603944A1 Elite event a2704-12 comprising the integration of the phosphinothricin acetyltransferase (pat) gene into soybeans, and methods and kits for identifying such event in biological samples |
| 10/19/2006 | CA2603940A1 Antibodies against mammalian metapneumovirus |
| 10/19/2006 | CA2603863A1 Gammaretrovirus associated with cancer |
| 10/19/2006 | CA2603842A1 Rnai therapeutic for respiratory virus infection |
| 10/19/2006 | CA2603780A1 Sema4d in cancer diagnosis, detection and treatment |
| 10/19/2006 | CA2603605A1 Genotyping hla loci |
| 10/19/2006 | CA2603542A1 Oxidizable species as an internal reference in control solutions for biosensors |
| 10/18/2006 | EP1712919A1 Analytical instrument having improved arrangement of reagent section and analytical method |
| 10/18/2006 | EP1712916A1 Biological sample discriminating device, biological sample discriminating method, and biological sample discriminating plate |
| 10/18/2006 | EP1712911A1 Method for detecting biomolecule, labeling dye used therefor, and labeling kit |
| 10/18/2006 | EP1712907A1 Biosensor and biosensor measuring device and method |
| 10/18/2006 | EP1712896A1 Device and method for detecting pollutants |